No Data
Apt Medical Inc. (688617.SH) subsidiary obtained a medical instruments registration certificate.
apt medical inc. (688617.SH) released an announcement that on November 21, 2024, its wholly-owned subsidiary hunan...
apt medical inc. (688617.SH): It is expected that consumables related to atrial fibrillation will gradually increase in volume in the second half of 2025.
Gelonghui, November 12th | apt medical inc. (688617.SH) stated on the interactive platform that the company expects the consumption of atrial fibrillation-related supplies to gradually increase in the second half of 2025; the company's management holds a cautious and optimistic attitude towards the increase in atrial fibrillation supplies.
We Think That There Are Issues Underlying APT Medical's (SHSE:688617) Earnings
Third Quarter Report 2024
apt medical inc. (688617.SH): net income for the first three quarters was 0.528 billion yuan, a year-on-year increase of 30.97%.
Gelonghui reported on October 25th that apt medical inc. (688617.SH) released its third-quarter report, with revenue of 1.52 billion yuan in the first three quarters, a year-on-year increase of 25.63%, net income of 0.528 billion yuan, a year-on-year increase of 30.97%, non-GAAP net income of 0.508 billion yuan, a year-on-year increase of 41.08%, and basic earnings per share of 5.44 yuan.
Is APT Medical Inc.'s (SHSE:688617) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
If EPS Growth Is Important To You, APT Medical (SHSE:688617) Presents An OpportunityNo Data
No Data
